• 25 March, 2025

Dr Reddy's Laboratories sued over cancer drug patent

September 23, 2013 | Monday | News | By BioSpectrum Bureau

Dr Reddy's Laboratories sued over cancer drug patent

Patent wars

Patent wars

In its petition, Genzyme alleged that Dr Reddy's had intimated through a letter that it had submitted an Abbreviated New Drug Application (ANDA) with the US FDA for approval to engage in the commercial manufacture, importation, use and sale of 20 mg/ml Plerixafor injection as a generic version of Mobozil.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up
New User? Create Account

Trending Topics

Most Read

Survey Box

Are Women Emerging as Power Players of Biotech Research & Policy?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy